TMAO: Why It Increases & Factors That May Reduce TMAO levels SelfDecode Labs This #GUTRecentAdvancesInBasicScience review synthesises emerging evidence linking the microbiome to cardiovascular disease, highlighting shared inflammatory and metabolic pathways. Fusco et al. present Gut microbiota and atherosclerosis access it Full article: Trimethylamine N oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target Identification of TMAO producer phenotype and hostdietgut dysbiosis by carnitine challenge test in human and germ free mice Gut Assembling the anaerobic gamma butyrobetaine to TMA metabolic pathway in Escherichia fergusonii and confirming its role in TMA production from dietary L carnitine in murine models mBio